Acetaminophen: Clinical Trials

149 trials of Acetaminophen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

107 completed, 10 terminated, 8 active not recruiting, 8 unknown. 149 Phase 1, 29 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1149Completed 107, Terminated 10, Active not recruiting 8, Unknown 8, Recruiting 6, Not yet recruiting 5, Withdrawn 4, Suspended 1
Phase 229Completed 16, Terminated 4, Unknown 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Withdrawn 1

Follow Acetaminophen: new trials by email Literature Review of Acetaminophen trials Research Report on Acetaminophen

Trials (filtered) newest first · largest first

All 149 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)
MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms
Phase 1Not yet recruitingMerck Sharp & Dohme LLC802026-11-132026-11-16
Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy
Celecoxib, Acetaminophen, Dexamethasone - Adenotonsillectomy, Postoperative Pain
Phase 1 / Phase 2Not yet recruitingNYU Langone Health5002026-11-012026-10-13
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Semaglutide, Placebo semaglutide, Paracetamol - Obesity, Overweight
Phase 1Not yet recruitingNovo Nordisk A/S602026-09-252026-09-29
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Tirzepatide, Acetaminophen, Placebo - Diabetes Mellitus, Type 1, Overweight
Phase 1RecruitingEli Lilly and Company182026-09-112026-09-23
Post-Vasectomy Pain Study
Acetaminophen, ibuprofen, oxycodone - Vasectomy, NSAIDs
Phase 1RecruitingColumbia University2002026-09-102026-09-24
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eloralintide, Placebo, Acetaminophen - Obesity, Overweight
Phase 1RecruitingEli Lilly and Company562026-07-312026-08-20
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
UBT251, Oral contraceptive, Acetaminophen - Overweight, Obesity
Phase 1RecruitingNovo Nordisk A/S402026-07-172026-08-25
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
Acetaminophen, Metformin, Warfarin - Overweight, Obesity
Phase 1Not yet recruitingHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.422026-04-082026-03-30
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
NNC0662-0419, Oral contraceptive, Acetaminophen - Overweight, Obesity
Phase 1Active not recruitingNovo Nordisk A/S412026-04-072026-09-30
A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity
PF-08653944, Acetaminophen - Obesity, Overweight and/or Obesity
Phase 1Active not recruitingPfizer222026-03-312026-07-09
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
HRS-7535 Tablets, Paracetamol Tablets, Digoxin Tablets - Obesity, Overweight
Phase 1CompletedShandong Suncadia Medicine Co., Ltd.402025-12-072026-06-29
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
AZD6234, Ethinyl estradiol/Levonorgestrel (EE/LEVO), Acetaminophen (APAP) - Healthy Participants
Phase 1Active not recruitingAstraZeneca1002025-06-042026-10-13
A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants
BMS-986446 IV, BMS-986446 SC, Acetaminophen - Healthy Volunteer
Phase 1CompletedBristol-Myers Squibb462025-05-052025-10-01
The Effect of AMG 133 on Gastric Emptying
AMG 133, Placebo, Acetaminophen - Overweight or Obesity
Phase 1CompletedAmgen572025-04-172026-02-24
A Study of BGM0504 in Overweight or Obese Participants
Paracetamol, Metformin Hydrochloride, Warfarin - Overweight or Obese
Phase 1CompletedBrightGene Bio-Medical Technology Co., Ltd.282025-03-252026-10-13
A Randomized Clinical Trial of the Effectiveness of Acupressure in Relieving Orthodontic Pain
Acetaminophen, Acupressure - Orthodontic Pain (D013850), Pain Management (D016146)
Phase 1Not yet recruitingUniversity of Baghdad562025-02-102025-02-10
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects
HRS-4729 injection, HRS-4729 injection placebo, HRS9531 injection - Overweight or Obesity
Phase 1CompletedFujian Shengdi Pharmaceutical Co., Ltd.1022025-01-162026-04-30
Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects
Acetaminophen, Metformin, Warfarin - Type 2 Diabetes
Phase 1CompletedFujian Shengdi Pharmaceutical Co., Ltd.572024-12-182025-06-22
Patient Controlled Administration of Liquid Acetaminophen
Acetaminophen 650 mg Oral Tablet, Acetaminophen 650mg Liquid, CADD pump - Pain, Pain, Postoperative
Phase 1CompletedYale University242024-11-192026-08-06
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
Pentavalent Meningococcal ABCYW vaccine, MenACYW conjugate vaccine, Meningococcal group B vaccine - Meningococcal Immunization, Healthy Volunteers
Phase 1 / Phase 2Active not recruitingSanofi Pasteur, a Sanofi Company7502024-11-052026-01-20

Showing 20 of 149. Sign in to see all of them.

Conditions studied

Obesity (17)  ·  Overweight (16)  ·  Pain (11)  ·  Pain, Postoperative (10)  ·  Agnosia (8)  ·  Diabetes Mellitus, Type 2 (5)  ·  Lymphoma, Non-Hodgkin (5)  ·  Ductus Arteriosus, Patent (4)  ·  Osteoarthritis (4)  ·  Acute Pain (3)  ·  Burkitt Lymphoma (3)  ·  Fever (3)  ·  Hodgkin Disease (3)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3)  ·  Lymphoma (3)

Sponsors

National Cancer Institute (NCI) (14)  ·  University Hospital, Clermont-Ferrand (8)  ·  Novo Nordisk A/S (7)  ·  GlaxoSmithKline (6)  ·  Merck Sharp & Dohme LLC (5)  ·  Eli Lilly and Company (4)  ·  AstraZeneca (3)  ·  Boehringer Ingelheim (3)  ·  Janssen Korea, Ltd., Korea (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  University Medicine Greifswald (3)  ·  Bayer (2)  ·  Baylor College of Medicine (2)  ·  Daewon Pharmaceutical Co., Ltd. (2)  ·  David Chi, MD (2)

Countries

United States (70)  ·  France (12)  ·  Germany (10)  ·  China (9)  ·  Canada (7)  ·  South Korea (6)  ·  Spain (6)  ·  United Kingdom (5)  ·  Denmark (4)  ·  Finland (4)  ·  Brazil (3)  ·  Egypt (3)  ·  Italy (3)  ·  Mexico (3)  ·  Taiwan (3)

Top investigators

David H Chi, MD (2)  ·  James L Gulley, M.D. (2)  ·  Jeffrey Bluestone, PhD (2)

Results publications

PMID 17397460, PMID 19217726, PMID 20934693, PMID 21300401, PMID 21340616, PMID 21518322, PMID 21792552, PMID 23415783, PMID 23551925, PMID 24030379, PMID 25734008, PMID 26225223, PMID 26229445, PMID 26951240, PMID 28630120, PMID 28637662, PMID 28752679, PMID 29274831, PMID 29667449, PMID 30227893, PMID 30471141, PMID 30908574, PMID 31113777, PMID 32078124, PMID 32416981, PMID 32702298, PMID 33078388, PMID 33112184, PMID 33306989, PMID 33335322, PMID 33558725, PMID 33602696, PMID 33617777, PMID 33713216, PMID 33907224, PMID 34280257, PMID 34480858, PMID 34687939, PMID 34889384, PMID 35135601, PMID 35170228, PMID 35410754, PMID 35605184, PMID 35622074, PMID 35800670, PMID 35819312, PMID 35876974, PMID 36322627, PMID 36882409, PMID 37138460

NIH funding

2023 (3), 2009 (2), 2014 (1), 2015 (1), 2018 (1), 2019 (1), P30CA033572 (1), R34AI095135 (1), U01AI110658 (1)